TGFB1 and diabetic kidney disease: Studies indicate that multiple mechanisms, including AGEs deposition, transforming growth factor-β (TGFβ) activation, platelet-derived growth factor B (PDGF-B), Angiotensin II (AngII, Ang2), and microRNAs, participate in the occurrence of EndMT in GECs during DKD (64).